[Mechanisms for castration-resistance of prostate carcinoma].
Prostate cancer is the most prevalent male urogenital malignancy. The tumor cells are prone to castration-resistance after androgen deprivation therapy. Variation and reactivation of androgen receptor, and the change in the tumor microenvironment are the major pathological factors for development of castration-resistant prostate carcinoma (CRPC). Systematically analyzing and understanding the mechanisms for castration-resistance of prostate carcinoma will be significant for laying the basis for improvement of the strategies on precise treatment for CRPC.